ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve New $5 Million Program For Reagent Contracts.

July 10, 2009

Reorganization Of Making Program Is Proposed

June 22, 1990

Subcommittee chairman Critical Of DCR For Lack Of “Game Plan”

October 28, 1977

DCT Adopts New Unsolicited Contract Review Procedures

May 21, 1976

Centers, Groups, Others May Land in DeVita’s Office; Hammer Offers Deal congress Can’t Refuse

February 5, 1988

In Brief: NCI To Push “Cancer Prevention Awareness” This Month; Three RFPs Delayed For Changes

February 17, 1984